{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T02:22:36Z","timestamp":1789698156131,"version":"4.0.1"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T00:00:00Z","timestamp":1765238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004434","name":"University of Florence","doi-asserted-by":"crossref","award":["RICTD2024-2025 project VANGUARD)"],"award-info":[{"award-number":["RICTD2024-2025 project VANGUARD)"]}],"id":[{"id":"10.13039\/501100004434","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004434","name":"University of Florence","doi-asserted-by":"crossref","award":["Fondi di Ateneo"],"award-info":[{"award-number":["Fondi di Ateneo"]}],"id":[{"id":"10.13039\/501100004434","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004434","name":"University of Florence","doi-asserted-by":"crossref","award":["Fondi di Ateneo"],"award-info":[{"award-number":["Fondi di Ateneo"]}],"id":[{"id":"10.13039\/501100004434","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004434","name":"University of Florence","doi-asserted-by":"crossref","award":["Fondi di Ateneo"],"award-info":[{"award-number":["Fondi di Ateneo"]}],"id":[{"id":"10.13039\/501100004434","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004434","name":"University of Florence","doi-asserted-by":"crossref","award":["Fondi di Ateneo"],"award-info":[{"award-number":["Fondi di Ateneo"]}],"id":[{"id":"10.13039\/501100004434","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Italian MUR - National Recovery and Resilience Plan","award":["project MNESYS (PE0000006) - A Multiscale integrated approach to the study of the nervous system in health and disease (D.R. 1553 11.10.2022)"],"award-info":[{"award-number":["project MNESYS (PE0000006) - A Multiscale integrated approach to the study of the nervous system in health and disease (D.R. 1553 11.10.2022)"]}]},{"name":"Italian MUR - National Recovery and Resilience Plan","award":["Investment PE8 - Project Age-It: \u201cAgeing Well in an Ageing Society\u201d (D.R. 1557 11.10.2022)"],"award-info":[{"award-number":["Investment PE8 - Project Age-It: \u201cAgeing Well in an Ageing Society\u201d (D.R. 1557 11.10.2022)"]}]},{"name":"Italian MUR - National Recovery and Resilience Plan","award":["project MNESYS (PE0000006) - A Multiscale integrated approach to the study of the nervous system in health and disease (D.R. 1553 11.10.2022)"],"award-info":[{"award-number":["project MNESYS (PE0000006) - A Multiscale integrated approach to the study of the nervous system in health and disease (D.R. 1553 11.10.2022)"]}]},{"name":"Italian MUR - National Recovery and Resilience Plan","award":["Investment PE8 - Project Age-It: \u201cAgeing Well in an Ageing Society\u201d (D.R. 1557 11.10.2022)"],"award-info":[{"award-number":["Investment PE8 - Project Age-It: \u201cAgeing Well in an Ageing Society\u201d (D.R. 1557 11.10.2022)"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Biosci"],"DOI":"10.1186\/s13578-025-01479-7","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T05:47:08Z","timestamp":1765259228000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cellular prion protein and calcium ions trigger the neurotoxicity of \u03b1-synuclein aggregates"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1067-6288","authenticated-orcid":false,"given":"Alessandra","family":"Bigi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea Carlotta","family":"Conti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liliana","family":"Napolitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3644-9809","authenticated-orcid":false,"given":"Giuliana","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8789-9546","authenticated-orcid":false,"given":"Alfonso","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1330-1289","authenticated-orcid":false,"given":"Fabrizio","family":"Chiti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9856-6843","authenticated-orcid":false,"given":"Roberta","family":"Cascella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8387-7737","authenticated-orcid":false,"given":"Cristina","family":"Cecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,9]]},"reference":[{"key":"1479_CR1","doi-asserted-by":"crossref","unstructured":"McCann H, Stevens CH,Cartwright H, Halliday GM. \u03b1-Synucleinopathy pheno\u00adtypes. Parkinsonism Relat Disord. 2014;20 Suppl 1:S62\u20137.","DOI":"10.1016\/S1353-8020(13)70017-8"},{"issue":"s1","key":"1479_CR2","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.3233\/JPD-179005","volume":"7","author":"M Goedert","year":"2017","unstructured":"Goedert M, Jakes R, Spillantini MG. The synucleinopathies: twenty years on. J Parkinsons Dis. 2017;7(s1):S51\u201369.","journal-title":"J Parkinsons Dis"},{"key":"1479_CR3","doi-asserted-by":"crossref","unstructured":"Winner B, Jappelli R, Maji SK, Desplats PA, Boyer L, Aigner S, et al. In vivo demonstration that alpha-synuclein oligomers are toxic. Proc Natl Acad Sci USA. 2011;108(10):4194\u20139.","DOI":"10.1073\/pnas.1100976108"},{"key":"1479_CR4","doi-asserted-by":"crossref","unstructured":"Cremades N, Cohen SI, Deas E, Abramov AY, Chen AY, et al. Direct observation of the interconversion of normal and toxic forms of alpha-synuclein. Cell. 2012;149(5):1048\u201359.","DOI":"10.1016\/j.cell.2012.03.037"},{"key":"1479_CR5","doi-asserted-by":"crossref","unstructured":"Fusco G, Chen SW, Williamson PTF, Cascella R, Perni M, et al. Structural basis of membrane disruption and cellular toxicity by \u03b1-synuclein oligomers. Science. 2017;358(6369):1440.","DOI":"10.1126\/science.aan6160"},{"key":"1479_CR6","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/978-1-4939-9124-2_14","volume":"1948","author":"ES Luth","year":"2019","unstructured":"Luth ES, Stavrovskaya IG. Measuring mitochondrial dysfunction caused by soluble \u03b1-synuclein oligomers. Methods Mol Biol. 2019;1948:183\u201398.","journal-title":"Methods Mol Biol"},{"key":"1479_CR7","unstructured":"Yang W, Li X, Yin N. \u03b1-Syn oligomers incubated with Parkinson's disease plasma promote neuron damage. Int J Clin Exp Pathol. 2020;13(8):1995\u20132008."},{"issue":"1","key":"1479_CR8","first-page":"1814","volume":"12","author":"R Cascella","year":"2021","unstructured":"Cascella R, Chen SW, Bigi A, Camino JD, Xu CK, et al. The release of toxic oligomers from \u03b1-synuclein fibrils induces dysfunction in neuronal cells. Nat Commun. 2021;12(1):1814.","journal-title":"NatCommun."},{"key":"1479_CR9","doi-asserted-by":"crossref","unstructured":"Bigi A, Ermini E, Chen SW, Cascella R, Cecchi C. Exploring the Release of Toxic Oligomers from \u03b1-Synuclein Fibrils with Antibodies and STED Microscopy. Life (Basel). 2021;11(5):431.","DOI":"10.3390\/life11050431"},{"key":"1479_CR10","doi-asserted-by":"crossref","unstructured":"Bigi A, Cascella R, Chiti F, Cecchi C. Amyloid fibrils act as a reservoir of soluble oligomers, the main culprits in protein deposition diseases. Bioessays. 2022;44(11):e2200086.","DOI":"10.1002\/bies.202200086"},{"issue":"1","key":"1479_CR11","doi-asserted-by":"publisher","first-page":"5512","DOI":"10.1038\/s41467-022-33252-6","volume":"13","author":"D Emin","year":"2022","unstructured":"Emin D, Zhang YP, Lobanova E, Miller A, Li X, et al. Small soluble \u03b1-synuclein aggregates are the toxic species in Parkinson's disease. Nat Commun. 2022;13(1):5512.","journal-title":"Nat Commun."},{"issue":"11","key":"1479_CR12","doi-asserted-by":"publisher","first-page":"2332","DOI":"10.4103\/1673-5374.371345","volume":"18","author":"A Bigi","year":"2023","unstructured":"Bigi A, Cascella R, Cecchi C. \u03b1-Synuclein oligomers and fibrils: partners in crime in synucleinopathies. Neural Regen Res. 2023;18(11):2332\u201342.","journal-title":"Neural Regen Res."},{"issue":"1","key":"1479_CR13","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s13024-023-00651-2","volume":"19","author":"DJ Rinauro","year":"2024","unstructured":"Rinauro DJ, Chiti F, Vendruscolo M, Limbocker R. Misfolded protein oligomers: mechanisms of formation, cytotoxic effects, and pharmacological approaches against protein misfolding diseases. Mol Neurodegener. 2024;19(1):20.","journal-title":"Mol Neurodegener."},{"key":"1479_CR14","doi-asserted-by":"crossref","unstructured":"Cascella R, Perni M, Chen SW, Fusco G, Cecchi C, et al. Probing the origin of the toxicity of oligomeric aggregates of \u03b1-synuclein with antibodies. ACS Chem Biol. 2019;14(6):1352\u201362.","DOI":"10.1021\/acschembio.9b00312"},{"issue":"16","key":"1479_CR15","doi-asserted-by":"publisher","first-page":"E1994","DOI":"10.1073\/pnas.1421204112","volume":"112","author":"SW Chen","year":"2015","unstructured":"Chen SW, Drakulic S, Deas E, Ouberai M, Aprile FA, et al. Structural characterization of toxic oligomers that are kinetically trapped during \u03b1-synuclein fibril formation. Proc Natl Acad Sci USA. 2015;112(16):E1994\u20132003.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1479_CR16","doi-asserted-by":"crossref","unstructured":"Camino JD, Gracia P, Chen SW, Sot J, de la Arada I, et al. The extent of protein hydration dictates the preference for heterogeneous or homogeneous nucleation generating either parallel or antiparallel \u03b2-sheet \u03b1-synuclein aggregates. Chem Sci. 2020;11(43):11902\u201314.","DOI":"10.1039\/D0SC05297C"},{"issue":"3","key":"1479_CR17","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s00018-022-04166-9","volume":"79","author":"R Cascella","year":"2022","unstructured":"Cascella R, Bigi A, Cremades N, Cecchi C. Effects of oligomer toxicity, fibril toxicity and fibril spreading in synucleinopathies. Cell Mol Life Sci. 2022;79(3):174.","journal-title":"Cell Mol Life Sci."},{"key":"1479_CR18","doi-asserted-by":"crossref","unstructured":"Froula JM, Castellana-Cruz M, Anabtawi NM, Camino JD, Chen SW, et al. Defining \u03b1-synuclein species responsible for Parkinson's disease phenotypes in mice. J Biol Chem. 2019;294(27):10392\u2013406.","DOI":"10.1074\/jbc.RA119.007743"},{"issue":"11","key":"1479_CR19","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/S1474-4422(10)70213-1","volume":"9","author":"E Angot","year":"2010","unstructured":"Angot E, Steiner JA, Hansen C, Li JY, Brundin P. Are synucleinopathies prion-like disorders? Lancet Neurol. 2010;9(11):1128\u201338.","journal-title":"Lancet Neurol"},{"key":"1479_CR20","doi-asserted-by":"crossref","unstructured":"Prusiner SB, Woerman AL, Mordes DA, Watts JC, Rampersaud R, et al. Evidence for \u03b1-synuclein prions causing multiple system atrophy in humans with parkinsonism. Proc Natl Acad Sci USA. 2015;112(38):E5308\u201317.","DOI":"10.1073\/pnas.1514475112"},{"key":"1479_CR21","doi-asserted-by":"crossref","unstructured":"Candelise N, Schmitz M, Llorens F, Villar-Piqu\u00e9 A, Cramm M, et al. Seeding variability of different alpha synuclein strains in synucleinopathies. Ann Neurol. 2019;85(5):691\u2013703.","DOI":"10.1002\/ana.25446"},{"key":"1479_CR22","doi-asserted-by":"crossref","unstructured":"Br\u00e1s IC, Outeiro TF. Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies. Cells. 2021;10(2):375.","DOI":"10.3390\/cells10020375"},{"key":"1479_CR23","doi-asserted-by":"crossref","unstructured":"Kim C, Ho DH, Suk JE, You S, Michael S, et al. Neuron-released oligomeric \u03b1-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia. Nat Commun. 2013;4:1562.","DOI":"10.1038\/ncomms2534"},{"key":"1479_CR24","doi-asserted-by":"crossref","unstructured":"Ferreira DG, Temido-Ferreira M, Miranda HV, Batalha VL, Coelho JE, et al. Alpha synuclein interacts with PrPC to induce cognitive impairment through mGluR5 and NMDAR2B. Nat Neurosci. 2017;20(11):1569\u201379.","DOI":"10.1038\/nn.4648"},{"issue":"1\u20132","key":"1479_CR25","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s11010-007-9664-6","volume":"310","author":"XF Wang","year":"2008","unstructured":"Wang XF, Dong CF, Zhang J, Wan YZ, Li F, Huang YX, et al. Human tau protein forms complex with PrP and some GSS- and fCJD-related PrP mutants possess stronger binding activities with tau in vitro. Mol Cell Biochem. 2008;310(1-2):49\u201355.","journal-title":"Mol Cell Biochem."},{"issue":"7233","key":"1479_CR26","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1038\/nature07761","volume":"457","author":"J Laur\u00e9n","year":"2017","unstructured":"Laur\u00e9n J, Gimbel DA, Nygaard HB, Gilbert JW, Strittmatter SM. Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature. 2009;457(7233):1128\u201332.","journal-title":"Nature."},{"key":"1479_CR27","doi-asserted-by":"crossref","unstructured":"Resenberger UK, Harmeier A, Woerner AC, Goodman JL, M\u00fcller V, et al. The cellular prion protein mediates neurotoxic signalling of \u03b2-sheet-rich conform\u00aders independent of prion replication. EMBO J. 2011;30(10):2057\u201370.","DOI":"10.1038\/emboj.2011.86"},{"issue":"17","key":"1479_CR28","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1002\/cbic.201402377","volume":"15","author":"KA Ganzinger","year":"2014","unstructured":"Ganzinger KA, Narayan P, Qamar SS, Weimann L, Ranasinghe RT, et al. Single-molecule imaging reveals that small amyloid-\u03b21-42 oligomers interact with the cellular prion protein (PrP(C)). Chembiochem. 2014;15(17):2515\u201321.","journal-title":"Chembiochem."},{"key":"1479_CR29","doi-asserted-by":"crossref","unstructured":"Scott-McKean JJ, Surewicz K, Choi JK, Ruffin VA, Salameh AI, et al. Soluble prion protein and its N-terminal fragment prevent impairment of synaptic plasticity by A\u03b2 oligomers: Implications for novel therapeutic strategy in Alzheimer's disease. Neurobiol Dis. 2016;91:124\u2013131.","DOI":"10.1016\/j.nbd.2016.03.001"},{"issue":"9","key":"1479_CR30","doi-asserted-by":"publisher","first-page":"4914","DOI":"10.3390\/ijms22094914","volume":"22","author":"R Cascella","year":"2021","unstructured":"Cascella R, Cecchi C. Calcium dyshomeostasis in Alzheimer's disease pathogenesis. Int J Mol Sci. 2021;22(9):4914.","journal-title":"Int J Mol Sci."},{"key":"1479_CR31","doi-asserted-by":"crossref","unstructured":"Auli\u0107 S, Masperone L, Narkiewicz J, Isopi E, Bistaffa E et al. \u03b1-Synuclein amyloids hijack prion protein to gain cell entry, facilitate cell-to-cell spreading and block prion replication. Sci Rep. 2017;7(1):10050.","DOI":"10.1038\/s41598-017-10236-x"},{"issue":"3","key":"1479_CR32","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1007\/s12035-017-0451-4","volume":"55","author":"L Urrea","year":"2018","unstructured":"Urrea L, Segura-Feliu M, Masuda-Suzukake M, Hervera A, Pedraz L, et al. Involvement of cellular prion protein in \u03b1-synuclein transport in neurons. Mol Neurobiol. 2018;55(3):1847\u201360.","journal-title":"Mol Neurobiol."},{"issue":"4","key":"1479_CR33","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1038\/s41419-024-06630-9","volume":"15","author":"MI Oliveirada Silva","year":"2024","unstructured":"Oliveira da Silva MI, Santejo M, Babcock IW, Magalh\u00e3es A, Minamide LS, et al. \u03b1-Synuclein triggers cofilin pathology and dendritic spine impairment via a PrPC-CCR5 dependent pathway. Cell Death Dis. 2024;15(4):264.","journal-title":"Cell Death Dis."},{"issue":"3","key":"1479_CR34","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s00401-019-02114-9","volume":"139","author":"GT Corbett","year":"2020","unstructured":"Corbett GT, Wang Z, Hong W, Colom-Cadena M, Rose J, et al. PrP is a central player in toxicity mediated by soluble aggregates of neurodegeneration-causing proteins. Acta Neuropathol. 2020;139(3):503\u2013526.","journal-title":"Acta Neuropathol."},{"key":"1479_CR35","doi-asserted-by":"crossref","unstructured":"Thom T, Schmitz M, Fischer AL, Correia A, Correia S, et al. Cellular prion protein mediates \u03b1-synuclein uptake, localization, and toxicity in vitro and in vivo. Mov Disord. 2022;37(1):39\u201351.","DOI":"10.1002\/mds.28774"},{"issue":"1","key":"1479_CR36","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s42003-020-1085-z","volume":"3","author":"NS R\u00f6sener","year":"2020","unstructured":"R\u00f6sener NS, Gremer L, W\u00f6rdehoff MM, Kupreichyk T, Etzkorn M, et al. Clustering of human prion protein and \u03b1-synuclein oligomers requires the prion protein N-terminus. Commun Biol. 2020;3(1):365.","journal-title":"Commun Biol."},{"key":"1479_CR37","doi-asserted-by":"crossref","unstructured":"La Vitola P, Beeg M, Balducci C, Santamaria G, Restelli E, et al. Cellular prion protein neither binds to alpha-synuclein oligomers nor mediates their detrimental effects. Brain. 2019;142(2):249\u201354.","DOI":"10.1093\/brain\/awy318"},{"key":"1479_CR38","doi-asserted-by":"crossref","unstructured":"So RWL, Amano G, Stuart E, Ebrahim Amini A, Aguzzi A, et al. \u03b1-Synuclein strain propagation is independent of cellular prion protein expression in a transgenic synucleinopathy mouse model. PLoS Pathog. 2024;20(9):e1012517.","DOI":"10.1371\/journal.ppat.1012517"},{"issue":"1","key":"1479_CR39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s13195-023-01361-z","volume":"16","author":"A Bigi","year":"2024","unstructured":"Bigi A, Napolitano L, Vadukul DM, Chiti F, Cecchi C, et al. A single-domain antibody detects and neutralises toxic A\u03b242 oligomers in the Alzheimer\u2019s disease CSF. Alzheimers Res Ther. 2024;16(1):13.","journal-title":"Alzh Res Ther."},{"key":"1479_CR40","doi-asserted-by":"crossref","unstructured":"Capitini C, Bigi A, Parenti N, Emanuele M, Bianchi N, et al. APP and Bace1: differential effect of cholesterol enrichment on processing and plasma membrane mobility. iScience. 2023;26(5):106611.","DOI":"10.1016\/j.isci.2023.106611"},{"issue":"8","key":"1479_CR41","doi-asserted-by":"publisher","first-page":"722","DOI":"10.2174\/1567205017666201109093848","volume":"17","author":"A Bigi","year":"2020","unstructured":"Bigi A, Loffredo G, Cascella R, Cecchi C. Targeting pathological amyloid aggregates with conformation-sensitive antibodies. Curr Alzheimer Res. 2020;17(8):722\u201334.","journal-title":"Curr Alzheimer Res."},{"key":"1479_CR42","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1007\/978-1-62703-056-4_5","volume":"931","author":"J Adler","year":"2013","unstructured":"Adler J, Parmryd I. Colocalization analysis in fluorescence microscopy. Methods Mol Biol. 2013;931:97\u2013109.","journal-title":"Methods Mol Biol."},{"issue":"4","key":"1479_CR43","doi-asserted-by":"publisher","first-page":"C723","DOI":"10.1152\/ajpcell.00462.2010","volume":"300","author":"KW Dunn","year":"2011","unstructured":"Dunn KW, Kamocka MM, McDonald JH. A practical guide to evaluating colocalization in biological microscopy. Am J Physiol Cell Physiol. 2011;300(4):C723\u201342.","journal-title":"Am J Physiol"},{"issue":"1","key":"1479_CR44","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1111\/febs.16579","volume":"290","author":"A Bigi","year":"2023","unstructured":"Bigi A, Cascella R, Fani G, Bernacchioni C, Cencetti F, et al. Sphingosine 1-phosphate attenuates neuronal dysfunction induced by amyloid-\u03b2 oligomers through endocytic internalization of NMDA receptors. FEBS J. 2023;290(1):112\u2013133.","journal-title":"FEBS J."},{"issue":"1","key":"1479_CR45","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1186\/s13024-017-0149-0","volume":"12","author":"H Xicoy","year":"2017","unstructured":"Xicoy H, Wieringa B, Martens GJ. The SH-SY5Y cell line in Parkinson\u2019s disease research: a systematic review. Mol Neurodegener. 2017;12(1):10.","journal-title":"Mol Neurodegener."},{"issue":"1","key":"1479_CR46","first-page":"139","volume":"9","author":"E Rezvani Boroujeni","year":"2023","unstructured":"Rezvani Boroujeni E, Hosseini SM, Fani G, Cecchi C, Chiti F. Soluble prion peptide 107-120 protects neuroblastoma SH-SY5Y cells against oligomers associated with Alzheimer's disease. Int J Mol Sci. 2020;21(19):7273.","journal-title":"Int"},{"issue":"5618","key":"1479_CR47","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1126\/science.1079469","volume":"300","author":"R Kayed","year":"2003","unstructured":"Kayed R, Head E, Thompson JL, McIntire TM, Milton SC, et al. Common structure of soluble amyloid oligomers implies common mechanism of pathogenesis. Science. 2003;300(5618):486\u20139.","journal-title":"Science."},{"issue":"34","key":"1479_CR48","doi-asserted-by":"publisher","first-page":"9220","DOI":"10.1523\/JNEUROSCI.2617-07.2007","volume":"27","author":"KM Danzer","year":"2007","unstructured":"Danzer KM, Haasen D, Karow AR, Moussaud S, Habeck M, et al. Different species of alpha-synuclein oligomers induce calcium influx and seeding. J Neurosci. 2007;27(34):9220\u201332.","journal-title":"J Neurosci."},{"issue":"9","key":"1479_CR49","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1242\/jcs.180737","volume":"129","author":"PR Angelova","year":"2016","unstructured":"Angelova PR, Ludtmann MH, Horrocks MH, Negoda A, Cremades N, et al. Ca2+ is a key factor in \u03b1-synuclein-induced neurotoxicity. J Cell Sci. 2016;129(9):1792\u2013801.","journal-title":"J Cell Sci."},{"key":"1479_CR50","doi-asserted-by":"crossref","unstructured":"Ito N, Tsuji M, Adachi N, Nakamura S, Sarkar AK, et al. Extracellular high molecular weight \u03b1-synuclein oligomers induce cell death by disrupting the plasma membrane. NPJ Parkinsons Dis. 2023;9(1):139.","DOI":"10.1038\/s41531-023-00583-0"},{"issue":"1\u20132","key":"1479_CR51","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/0022-1759(94)90147-3","volume":"177","author":"NG Papadopoulos","year":"1994","unstructured":"Papadopoulos NG, Dedoussis GV, Spanakos G, Gritzapis AD, Baxevanis CN, et al. An improved fluorescence assay for the determination of lymphocyte-mediated cytotoxicity using flow cytometry. J Immunol Methods. 1994;177(1\u20132):101\u201311.","journal-title":"J Immunol Meth."},{"key":"1479_CR52","doi-asserted-by":"crossref","unstructured":"Lautenschl\u00e4ger J, Stephens AD, Fusco G, Str\u00f6hl F, Curry N, et al. C-terminal calcium binding of \u03b1-synuclein modulates synaptic vesicle interaction. Nat Commun. 2018;9(1):712.","DOI":"10.1038\/s41467-018-03111-4"},{"key":"1479_CR53","doi-asserted-by":"crossref","unstructured":"Byrd EJ, Wilkinson M, Radford SE, Sobott F. Taking charge: Metal Ions Acceler\u00adate Amyloid aggregation in sequence variants of \u03b1-synuclein. J Am Soc Mass Spectrom. 2023;34(3):493\u2013504.","DOI":"10.1021\/jasms.2c00379"},{"key":"1479_CR54","doi-asserted-by":"crossref","unstructured":"Ondrejcak T, KlyubinI, Corbett GT, Fraser G, Hong W, et al. Cellular prion pro\u00adtein mediates the disruption of hippocampal synaptic plasticity by soluble Tau in vivo. J Neurosci. 2018;38(50):10595\u2013606.","DOI":"10.1523\/JNEUROSCI.1700-18.2018"},{"key":"1479_CR55","doi-asserted-by":"crossref","unstructured":"Legname G, Scial\u00f2 C. On the role of the cellular prion protein in the uptake and signaling of pathological aggregates in neurodegenerative diseases. Prion. 2020;14(1):257\u201370.","DOI":"10.1080\/19336896.2020.1854034"},{"key":"1479_CR56","doi-asserted-by":"crossref","unstructured":"Scial\u00f2 C, Celauro L, Zattoni M, Tran TH, Bistaffa E, et al. The Cellular Prion Protein Increases the Uptake and Toxicity of TDP-43 Fibrils. Viruses. 2021;13(8):1625.","DOI":"10.3390\/v13081625"},{"key":"1479_CR57","doi-asserted-by":"crossref","unstructured":"Liu S, Li S, Lin J, Li J, Yang H. Aptamer-induced-dimerization strategy attenu\u00adates A\u03b2O toxicity through modulating the trophic activity of PrPC signaling. J Am Chem Soc. 2022;144(21):9264\u201370.","DOI":"10.1021\/jacs.2c00287"},{"key":"1479_CR58","doi-asserted-by":"crossref","unstructured":"Celauro L, Legname G. The cellular prion protein as universal receptor for amyloid proteins. In: Mani, I. (eds) Neuroreceptor Endocytosis and Signaling in Health and Disease. The Receptors, vol 2. Humana, Cham. 2025.","DOI":"10.1007\/978-3-031-81991-9_18"},{"issue":"5","key":"1479_CR59","doi-asserted-by":"publisher","first-page":"2295","DOI":"10.1073\/pnas.0911829107","volume":"107","author":"C Balducci","year":"2010","unstructured":"Balducci C, Beeg M, Stravalaci M, Bastone A, Sclip A, et al. Synthetic amyloid-beta oligomers impair long-term memory independently of cellular prion protein. Proc Natl Acad Sci USA. 2010;107(5):2295\u2013300.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"8","key":"1479_CR60","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1002\/emmm.201000082","volume":"2","author":"AM Calella","year":"2010","unstructured":"Calella AM, Farinelli M, Nuvolone M, Mirante O, Moos R, et al. Prion protein and Abeta-related synaptic toxicity impairment. EMBO Mol Med. 2010;2(8):306\u201314.","journal-title":"EMBO Mol Med."},{"key":"1479_CR61","doi-asserted-by":"crossref","unstructured":"Kessels HW, Nguyen LN, Nabavi S, Malinow R. The prion protein as a receptor for amyloid-beta. Nature. 2010;466(7308):E3-4; discussion E4-5.","DOI":"10.1038\/nature09217"},{"issue":"4","key":"1479_CR62","doi-asserted-by":"publisher","first-page":"359","DOI":"10.3233\/JPD-2011-11067","volume":"1","author":"M Grey","year":"2011","unstructured":"Grey M, Linse S, Nilsson H, Brundin P, Sparr E. Membrane interaction of alpha-synuclein in different aggregation states. J. Parkinsons Dis. 2011;1(4):359\u2212371.","journal-title":"J. Parkinsons Dis."},{"issue":"5","key":"1479_CR63","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1016\/j.bbapap.2018.10.006","volume":"1867","author":"A Iyer","year":"2019","unstructured":"Iyer A, Claessens MMAE. Disruptive membrane interactions of alpha-synuclein aggregates. Biochim Biophys Acta Proteins Proteom. 2019;1867(5):468\u201382.","journal-title":"Biochim Biophys Acta Proteins Proteom."},{"key":"1479_CR64","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1146\/annurev-pathol-031920-092547","volume":"16","author":"G Runwal","year":"2021","unstructured":"Runwal G, Edwards RH. The Membrane Interactions of Synuclein: Physiology and Pathology. Annu Rev Pathol. 2021;16:465\u201385.","journal-title":"Annu Rev Pathol."},{"key":"1479_CR65","doi-asserted-by":"crossref","unstructured":"Mansueto S, Fusco G, De Simone A. \u03b1-Synuclein and biological membranes: the danger of loving too much. Chem Commun (Camb). 2023;59(57):8769\u20138778.","DOI":"10.1039\/D3CC01682J"},{"key":"1479_CR66","doi-asserted-by":"crossref","unstructured":"Tamamizu-Kato S, Kosaraju MG, Kato H, Raussens V, Ruysschaert JM, et al. Calcium-triggered membrane interaction of the alpha-synuclein acidic tail. Biochemistry. 2006;45(36):10947\u201356.","DOI":"10.1021\/bi060939i"}],"container-title":["Cell &amp; Bioscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-025-01479-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13578-025-01479-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13578-025-01479-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T18:02:04Z","timestamp":1765303324000},"score":1,"resource":{"primary":{"URL":"https:\/\/cellandbioscience.biomedcentral.com\/articles\/10.1186\/s13578-025-01479-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,9]]},"references-count":66,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1479"],"URL":"https:\/\/doi.org\/10.1186\/s13578-025-01479-7","relation":{},"ISSN":["2045-3701"],"issn-type":[{"value":"2045-3701","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,9]]},"assertion":[{"value":"6 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"166"}}